Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription 08.09.2025 1 AIDS 1 BMJ 1 Clin Infect Dis 2 J Gen Virol 1 J Infect Dis 2 J Virol 4 JAMA 3 Lancet 3 N Engl J Med 1 Nat Med 2 Pediatrics 1 PLoS Comput Biol 1 PLoS Med 7 PLoS One 16 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. TODESCO E, Valantin MA, Akhavan S, Rouget R, et al
   Acute hepatitis B infections among PWH treated with 2-drug regimen: can we trust the vaccination status?
   AIDS. 2025;39:1845-1847.
   PubMed        
   
   

   
   BMJ

2. TANNE JH
   Florida moves to be the first US state to end vaccine mandates.
   BMJ. 2025;390:r1870.
   PubMed        
   
   

   
   Clin Infect Dis

3. GODIN A, Brickley EB, Connor RI, Wieland-Alter WF, et al
   Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newborns.
   Clin Infect Dis. 2025 Sep 5:ciaf484. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Gen Virol

4. PONSARD C, Chasseur AS, Lombard P, Danneels B, et al
   Conserved and distinct expression of circular RNAs in commercially used Marek's disease vaccine viruses.
   J Gen Virol. 2025;106.
   PubMed         Abstract available
   
   
5. TSCHERNE A, Kalodimou G, Jany S, Freudenstein A, et al
   Robust polyfunctional CD8(+) and CD4(+) T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein.
   J Gen Virol. 2025;106.
   PubMed         Abstract available
   
   

   
   J Infect Dis

6. VAN DEN BOSCH E, Vermeulen H, Ekinci E, Paranthoen L, et al
   Interplay between maternal Tdap and infant pneumococcal vaccination in shaping infant pneumococcal vaccine serotype carriage.
   J Infect Dis. 2025 Aug 30:jiaf458. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

7. HAGA Y, Babu E P, Swiderska-Syn M, Reagan EK, et al
   Hepatitis C virus modified (S)E2(F442NYT)-mRNA-LNP candidate vaccine promotes helper CXCR5(+)T cells.
   J Virol. 2025 Sep 5:e0135525. doi: 10.1128/jvi.01355.
   PubMed         Abstract available
   
   
8. OOM AL, Wilson KK, Yonatan M, Rettig S, et al
   Correction for Oom et al., "The two-dose MVA-BN mpox vaccine induces a nondurable and low avidity MPXV-specific antibody response".
   J Virol. 2025 Sep 4:e0087225. doi: 10.1128/jvi.00872.
   PubMed        
   
   

   
   JAMA

9. ANDERER S
   Breaking From CDC, ACOG Continues Recommending COVID-19 Vaccine During Pregnancy.
   JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.16943.
   PubMed        
   
   
10. LASSEN MCH, Johansen ND, Christensen SH, Aliabadi N, et al
    Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV Trial.
    JAMA. 2025 Aug 30:e2515405. doi: 10.1001/jama.2025.15405.
    PubMed         Abstract available
    
    
11. SURIE D, Self WH, Yuengling KA, Lauring AS, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.
    JAMA. 2025 Aug 30:e2515896. doi: 10.1001/jama.2025.15896.
    PubMed         Abstract available
    
    
12. CHU HY, Murray AF
    Shot Through the Heart-Can RSV Vaccination Reduce Risk of Cardiovascular Outcomes?
    JAMA. 2025 Aug 30. doi: 10.1001/jama.2025.16705.
    PubMed        
    
    

    
    Lancet

13. ANDERSON CS, Hua C, Wang Z, Wang C, et al
    Influenza vaccination to improve outcomes for patients with acute heart failure (PANDA II): a multiregional, seasonal, hospital-based, cluster-randomised, controlled trial in China.
    Lancet. 2025 Aug 28:S0140-6736(25)01485-0. doi: 10.1016/S0140-6736(25)01485.
    PubMed         Abstract available
    
    
14. BHATT AS, Vardeny O
    Influenza vaccination in heart failure: a shot worth taking?
    Lancet. 2025 Aug 28:S0140-6736(25)01679-4. doi: 10.1016/S0140-6736(25)01679.
    PubMed        
    
    
15. LEE K, Kohler J
    Good governance essential to expanding vaccine capacity and strengthening public trust.
    Lancet. 2025 Aug 29:S0140-6736(25)01681-2. doi: 10.1016/S0140-6736(25)01681.
    PubMed        
    
    

    
    N Engl J Med

16. PARDO-SECO J, Rodriguez-Tenreiro-Sanchez C, Gine-Vazquez I, Mallah N, et al
    High-Dose Influenza Vaccine to Reduce Hospitalizations.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509834.
    PubMed         Abstract available
    
    
17. LASSEN MCH, Johansen ND, Christensen SH, Aliabadi N, et al
    RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509810.
    PubMed         Abstract available
    
    
18. JOHANSEN ND, Modin D, Loiacono MM, Harris RC, et al
    High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509907.
    PubMed         Abstract available
    
    

    
    Nat Med

19. CHU HY, Janes H, Carone M, Gilbert PB, et al
    Improving the evidence base for COVID-19 vaccines.
    Nat Med. 2025 Sep 4. doi: 10.1038/s41591-025-03908.
    PubMed        
    
    

    
    Pediatrics

20. HOGAN C, He S, Dombkowski KJ, Patel P, et al
    Changes in Childhood Immunization Rates by County Characteristics in Michigan: 2017-2023.
    Pediatrics. 2025;156:e2025070781.
    PubMed         Abstract available
    
    
21. YONTS AB, Gaviria-Agudelo C, Ratner AJ, O'Leary ST, et al
    April 2025 ACIP Meeting Update: Influenza, COVID-19, HPV, RSV and Other Immunizations.
    Pediatrics. 2025 Jul 2. doi: 10.1542/peds.2025-072444.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

22. REYNE B, Kamiya T, Djidjou-Demasse R, Alizon S, et al
    Leaky or polarised immunity: Non-Markovian modelling highlights the impact of immune memory assumptions.
    PLoS Comput Biol. 2025;21:e1013399.
    PubMed         Abstract available
    
    

    
    PLoS Med

23. JIN S, Asakura TR, Murayama H, Niyukuri D, et al
    Vaccination strategies to achieve outbreak control for MPXV Clade I with a one-time mass campaign in sub-Saharan Africa: A scenario-based modelling study.
    PLoS Med. 2025;22:e1004726.
    PubMed         Abstract available
    
    

    
    PLoS One

24. STOLARCZUK JE, Sosa M, Pike M, Baranoff A, et al
    Transplacental transfer of maternal SARS-CoV-2 antibodies in dichorionic and monochorionic twin pregnancies.
    PLoS One. 2025;20:e0328137.
    PubMed         Abstract available
    
    
25. VISKUPIC F, Wiltse DL, Stenvig TE
    Nurses' attitudes about RSV vaccination for pregnant women and infants: Evidence from a cross-sectional survey.
    PLoS One. 2025;20:e0331326.
    PubMed         Abstract available
    
    
26. SEMANCIK CS, Fantin R, Butt J, Abdelnour A, et al
    SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures.
    PLoS One. 2025;20:e0331212.
    PubMed         Abstract available
    
    
27. STRBAC M, Ukropina S, Nikolic N, Masic K, et al
    Impact of health promotion strategies on HPV vaccination uptake: A descriptive epidemiological study (2019-2024).
    PLoS One. 2025;20:e0331592.
    PubMed         Abstract available
    
    
28. MOTAMEDI H, Shoja S, Abbasi M
    Correction: Immunoinformatic evaluation for the development of a potent multi-epitope vaccine against bacterial vaginosis caused by Gardnerella vaginalis.
    PLoS One. 2025;20:e0331745.
    PubMed         Abstract available
    
    
29. CATES ZP, Facciuolo A, Scruten E, Kusalik A, et al
    Peptide immunoarrays for rationale development of vaccines with enhanced cross-reactivity.
    PLoS One. 2025;20:e0330741.
    PubMed         Abstract available
    
    
30. DEN'O ZD, Paulos W, Markos D, Oche WO, et al
    Human papilloma virus vaccination uptake and associated factors among adolescent girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
    PLoS One. 2025;20:e0330760.
    PubMed         Abstract available
    
    

    
    Vaccine

31. HERNANDEZ NIETO A, Delgado D, Moreno VA, Lucero D, et al
    Factors influencing HPV vaccine initiation and intentions among Central American immigrant fathers in the United States: An exploratory cross-sectional study.
    Vaccine. 2025;63:127672.
    PubMed         Abstract available
    
    
32. DAIGLE D, Morales G, Hayford K, Haridy H, et al
    Recommendations for pneumococcal vaccination of at-risk children: a global overview (2022-2024).
    Vaccine. 2025;63:127669.
    PubMed         Abstract available
    
    
33. HASAN Z, Masood KI, Qaiser S, Kanji A, et al
    Corrigendum to "Comparative study of humoral and cellular immunity against SARS-CoV-2 induced by different COVID-19 vaccine types: Insights into protection against wildtype, Delta and JN.1 omicron strains" [Vaccine 59 (2025) 127270].
    Vaccine. 2025;63:127686.
    PubMed        
    
    
34. DEBELLUT F, Jit M, Portnoy A, Mvundura M, et al
    Valuing combination vaccines: an incomplete picture and a pathway to a broader view.
    Vaccine. 2025;63:127675.
    PubMed        
    
    
35. NALUBEGA P, Namugumya R, Kyohere M, Seeley J, et al
    A mix of views: Perspectives on pregnant women's participation in maternal vaccine trials.
    Vaccine. 2025;63:127627.
    PubMed         Abstract available
    
    
36. CHEON K, Buchwald UK, Hammitt LL, LeBlanc JJ, et al
    The impact of pneumococcal vaccination and nasopharyngeal colonization on the performance of a serotype-specific urine antigen detection (SSUAD) assay.
    Vaccine. 2025;62:127453.
    PubMed         Abstract available
    
    
37. DEGIUSEPPE JI
    Comprehensive assessment of the impact of universal rotavirus vaccination program on the burden of diarrheal disease in children after 10 years of implementation in Argentina.
    Vaccine. 2025;63:127681.
    PubMed         Abstract available
    
    
38. BALAM S, Kane F, Traore B, Konate D, et al
    Kinetics and seroprevalence of anti-SARS-CoV-2 antibodies in vaccinated and unvaccinated health workers in Bamako, Mali, November 2021-February 2023.
    Vaccine. 2025 Sep 1:127680. doi: 10.1016/j.vaccine.2025.127680.
    PubMed         Abstract available
    
    
39. MAYERLEN LI, Wong TAS, To A, Smith O, et al
    Thermostable bivalent & trivalent filovirus vaccines from insect cells: potency demonstrated after 3 months and 2 years.
    Vaccine. 2025;64:127684.
    PubMed         Abstract available
    
    
40. O'LEARY ST, Skenadore A, Mosley BS, Severson R, et al
    Boot camp translation: A novel method to increase human papillomavirus (HPV) vaccination uptake.
    Vaccine. 2025;63:127683.
    PubMed         Abstract available
    
    
41. OKOLI GN, Murphy C, Mak L, Cheng SMS, et al
    Estimates of SARS-CoV-2 vaccine effectiveness against outpatient medically attended SARS-CoV-2 infection from April 2023 through August 2024 in Hong Kong: A test-negative design study.
    Vaccine. 2025;63:127687.
    PubMed         Abstract available
    
    
42. ZHAO Z, Ma X, Milligan P, Cheung YB, et al
    Robust evaluation of vaccine effects based on estimation of vaccine efficacy curve.
    Vaccine. 2025;63:127673.
    PubMed         Abstract available
    
    
43. ZHOU Y, Wang H, Chu L, Chen K, et al
    Influenza vaccination hesitancy and decision between parental and grandparental caregivers of preschoolers: a comparative study.
    Vaccine. 2025;64:127696.
    PubMed         Abstract available
    
    
44. NOSAN G, Cerkvenik Skafar A
    Screen first, vaccinate later: Enhancing tuberculosis vaccination safety through newborn immunodeficiency screening.
    Vaccine. 2025;64:127679.
    PubMed         Abstract available
    
    
45. BECKERS F, Karkada N, Yang Y, Scott J, et al
    Adopting the estimand framework in prophylactic vaccine trials.
    Vaccine. 2025;64:127645.
    PubMed         Abstract available
    
    
46. IRVING SA, Groom HC, Belongia EA, Crane B, et al
    Differences in influenza vaccination coverage by race and ethnicity across age groups in the Vaccine Safety Datalink, 2017-18 through 2022-23 influenza seasons.
    Vaccine. 2025;64:127667.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.